US Healthcare: 3 Stocks Flip to Bullish Momentum

The broader US market continues to show signs of improving breadth, with the Altra Market score at 63.6. This reflects a healthy participation, as 63.82% of stocks are trading above their 20-day exponential moving average (EMA), 64.02% above their 50-day EMA, and 67.4% above their 200-day EMA. The market has also seen more advances than declines, with a 15-day score trend showing a positive shift of 9.4 points, suggesting that favorable setups are emerging for selective traders.

Within this context, the US Healthcare sector (USHEALTHCARE), despite holding an Altra Sector score of 65.0 and ranking third, has been flagged as 'bearish.' However, a closer look at its regime detail reveals it is 'starting to turn up,' evidenced by a positive 4-week relative strength (RS) trend of +0.05 and a Relative Strength RSI of 51.2, suggesting nascent strength. This nuanced picture indicates that while the sector as a whole may still be lagging, individual names are beginning to demonstrate significant shifts in momentum.

AltraOne provides a data-driven approach to identifying these shifts. The Altra Score, a momentum indicator from 0-100, gauges a stock's bullishness based on its EMA alignment and RSI trends across daily, weekly, and monthly timeframes. A higher score signifies stronger upward momentum. The Altra Market score reflects market breadth by tracking the percentage of stocks above key EMAs, offering a snapshot of overall market texture. The Altra Sector score applies this same logic to sectors, also ranking them by relative strength. On July 13, 2026, three prominent names in US Healthcare showed notable upticks in their Altra Scores, moving from neutral or bearish regimes to bullish ones, potentially signaling a broader turn for the sector.

BDX

Becton Dickinson (BDX) saw its Altra Score make a significant leap, climbing from 46.8 to 80.2, moving from a 'Neutral' to a 'Strong Bullish' momentum regime. This substantial increase places BDX firmly in a high-momentum category. The stock's current price is trading above its key EMAs, which is a bullish technical signal. Examining its Relative Strength Index (RSI) across multiple timeframes, the daily RSI stands at 55.14, indicating healthy buying interest. However, the weekly RSI is at 50.5 and the monthly at 47.05, suggesting that while daily momentum is building, the longer-term picture is still solidifying, or perhaps experiencing a more recent acceleration after a period of consolidation. It is worth noting that BDX experienced a bearish Weekly EMA Crossover on May 1, 2026, which may imply that while short-term momentum is strong, there could be underlying resistance or historical price action that traders should be aware of, preventing the stock from being 'top-down aligned' with all bullish signals across timeframes.

BIIB

Biogen (BIIB) also exhibited a powerful surge in its Altra Score, jumping from 51.2 to 91.0, shifting from a 'Neutral' to a 'Strong Bullish' stance. This is an even more robust display of momentum than BDX, placing BIIB among the highest-scoring stocks. Its price is currently positioned above its key EMAs, confirming the upward trend. The RSI readings for BIIB are particularly compelling: 56.35 on the daily chart, 61.53 on the weekly, and a strong 74.39 on the monthly. Such elevated RSI values across all timeframes typically indicate sustained buying pressure and strong bullish sentiment. Furthermore, BIIB recorded a bullish Weekly EMA Crossover back on September 19, 2025, which adds weight to its current strong momentum, indicating that this bullish trend has been developing over a longer period. Despite this, the stock is not currently 'top-down aligned,' which suggests that while its individual momentum is very high, some longer-term or market-wide technical alignments might still be pending.

GEHC

GE HealthCare (GEHC) also joined the bullish turn, with its Altra Score improving from 36.8 to 64.5, effectively moving from a 'Bearish' to a 'Bullish' momentum regime. While not as dramatically high as BIIB, this is a significant shift away from bearish sentiment. GEHC is also trading above its key EMAs, a positive sign of recent strength. Its daily RSI is at 54.64, showing some short-term upward thrust. However, the weekly RSI at 44.22 and monthly RSI at 35.99 suggest that the longer-term momentum is still weak or in a recovery phase. Similar to BDX, GEHC experienced a bearish Weekly EMA Crossover on March 13, 2026. This indicates that while the Altra Score has turned bullish based on multi-timeframe analysis, there are still technical challenges on longer timeframes that could present hurdles to sustained upward movement, explaining why it is also not 'top-down aligned.'

These shifts in BDX, BIIB, and GEHC within the US Healthcare sector suggest that while the sector as a whole might still be considered bearish by some metrics, individual stocks are demonstrating powerful momentum reversals. Traders and investors monitoring the sector may find these Altra Score shifts noteworthy as potential indicators of emerging strength.

What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.

Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.

Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.